Docebo Reports Second Quarter 2026 Results
Bullish near-term: raise in guidance and solid ARR growth suggest upside for DCBO within 1–3 months, with continued focus on enterprise wins.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish near-term: raise in guidance and solid ARR growth suggest upside for DCBO within 1–3 months, with continued focus on enterprise wins.
What happened and why it matters
Docebo posted Q2 2026 results with revenue up 13% to $68.7M and subscription revenue up 12% to $63.8M, aided by FX tailwinds. ARR rose to $255.1M (up 9.5% YoY) with ex-largest OEM ARR rising ~13.9%, and the company raised full-year guidance for both quarterly and annual targets. The Q2 highlights include strong enterprise wins (FedRAMP, Kentucky, Indiana, Mississippi) that broaden its public-sector footprint and support a durable growth trajectory, despite near-term operating cash flow weakness.
Guidance uplift signals higher revenue visibility and potential multiple expansion for a SaaS name with durable ARR growth. A decline in OEM concentration reduces customer-risk, while FedRAMP/public-sector wins broaden addressable markets. Near-term price action will depend on market reaction to the guidance, but the combination of higher annual targets and continued enterprise momentum supports upside.
Q2 2026 revenue rose 13% to $68.7M; subscription revenue up 12% to $63.8M.
ARR reached $255.1M, up 9.5% YoY; excluding the largest OEM, ARR up ~13.9%.
Guidance raised for Q3 and full-year 2026; FY2026 subscription $255.5–$257.5M, total $274.5–$276.5M.
Largest OEM now 2.5% of ARR vs 8.4% in 2025; OEM concentration improving.
Enterprise wins including FedRAMP, Kentucky, Indiana, Mississippi expand Docebo's public-sector footprint.
Category: Earnings. Docebo reports quarterly metrics, updates guidance, and highlights large enterprise wins, underscoring a transition toward enterprise-scale growth and a more diversified ARR mix. The mix shift away from a highly concentrated OEM exposure and expansion into FedRAMP-enabled public-sector deals align with a longer-term revenue growth trajectory and margin improvement potential.
More AI-analyzed coverage connected to this story